Skip to content
MedsAcross

Brand family

Caprelsa

Vandetanib · Genzyme
United States
Presentations
2
Markets
1

Caprelsa is a brand of Vandetanib marketed by Genzyme, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Vandetanib
Brand owner
Genzyme
Registered in
United States
Strengths and forms
100 mg tablet, 300 mg tablet

All presentations

MedicineManufacturerRegisterAvailability
Caprelsa 100 mg tabletOralGenzymeUS FDAAvailable on request
Caprelsa 300 mg tabletOralGenzymeUS FDAAvailable on request

Brand names and trademarks belong to their owners and are used only to identify products.

Request Caprelsa

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.